Literature DB >> 14678642

Clinical survey of Leishmania/HIV co-infection in Catania, Italy: the impact of highly active antiretroviral therapy (HAART).

R Russo1, L Nigro, G Panarello, A Montineri.   

Abstract

The clinical and parasitological features of visceral leishmaniasis (VL) were investigated, retrospectively, in 27 HIV-infected patients who attended the out-patient clinic of Catania University's Department of Infectious Diseases between 1990 and 1998. The aim was to evaluate the epidemiological, clinical, therapeutic and prognostic characteristics of the co-infection, to determine if there were any interactions between the two infections, and to see if the use of highly active antiretroviral therapy (HAART) had any impact on the leishmaniasis. The most dramatic observation was a marked, HAART-attributable reduction in the annual incidence of VL relapses among the patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678642     DOI: 10.1179/000349803225002624

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  9 in total

Review 1.  Leishmaniasis.

Authors:  T V Piscopo; A C Mallia
Journal:  Postgrad Med J       Date:  2006-10       Impact factor: 2.401

Review 2.  Leishmaniasis.

Authors:  Tonio V Piscopo; Charles Mallia Azzopardi
Journal:  Postgrad Med J       Date:  2007-02       Impact factor: 2.401

Review 3.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

4.  Specific noninvasive detection of Leishmania donovani in desquamated buccal cell swab samples from human visceral Leishmaniasis-HIV coinfected patients.

Authors:  Sushmita Das; Avishek Halder; Vidya Nand Rabidas; Abhishek Mandal; Pradeep Das
Journal:  J Clin Microbiol       Date:  2014-01-29       Impact factor: 5.948

5.  Five-year retrospective Italian multicenter study of visceral leishmaniasis treatment.

Authors:  Francesco Di Masi; Tamara Ursini; Maria Donata Iannece; Leonardo Chianura; Francesco Baldasso; Giuseppe Foti; Pietro Di Gregorio; Angelo Casabianca; Nunzio Storaci; Luciano Nigro; Claudia Colomba; Maria Grazia Marazzi; Giovanni Todaro; Giacinta Tordini; Giacomo Zanelli; Giovanni Cenderello; Nicola Acone; Ennio Polilli; Simona Migliore; Paolo Almi; Eligio Pizzigallo; Evangelista Sagnelli; Francesco Mazzotta; Rosario Russo; Lamberto Manzoli; Giustino Parruti
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

6.  Tropical Parasitic Infections in Individuals Infected with HIV.

Authors:  Emily E Evans; Mark J Siedner
Journal:  Curr Trop Med Rep       Date:  2017-10-16

Review 7.  Predictors of visceral leishmaniasis relapse in HIV-infected patients: a systematic review.

Authors:  Gláucia F Cota; Marcos R de Sousa; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2011-06-07

Review 8.  Leishmaniasis-HIV coinfection: current challenges.

Authors:  José Angelo Lauletta Lindoso; Mirella Alves Cunha; Igor Thiago Queiroz; Carlos Henrique Valente Moreira
Journal:  HIV AIDS (Auckl)       Date:  2016-10-07

9.  Visceral leishmaniasis and HIV/AIDS in Brazil: Are we aware enough?

Authors:  Marcia Leite de Sousa-Gomes; Gustavo Adolfo Sierra Romero; Guilherme Loureiro Werneck
Journal:  PLoS Negl Trop Dis       Date:  2017-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.